Dagmar Dolby Sells 100,000 Shares of Dolby Laboratories, Inc. (DLB) Stock

Dolby Laboratories, Inc. (NYSE:DLB) major shareholder Dagmar Dolby sold 100,000 shares of the firm’s stock in a transaction dated Wednesday, May 16th. The shares were sold at an average price of $62.82, for a total transaction of $6,282,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Major shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Dagmar Dolby also recently made the following trade(s):

  • On Monday, May 14th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $62.65, for a total transaction of $6,265,000.00.
  • On Thursday, May 10th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $62.23, for a total transaction of $6,223,000.00.
  • On Tuesday, May 8th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $61.78, for a total transaction of $6,178,000.00.
  • On Friday, May 4th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $61.03, for a total transaction of $6,103,000.00.
  • On Wednesday, May 2nd, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $60.81, for a total transaction of $6,081,000.00.
  • On Friday, April 27th, Dagmar Dolby sold 50,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $60.39, for a total transaction of $3,019,500.00.
  • On Monday, April 30th, Dagmar Dolby sold 88,538 shares of Dolby Laboratories stock. The shares were sold at an average price of $60.28, for a total transaction of $5,337,070.64.

Shares of DLB stock opened at $62.47 on Friday. Dolby Laboratories, Inc. has a 12-month low of $48.00 and a 12-month high of $74.29. The company has a market cap of $6.54 billion, a PE ratio of 28.40, a P/E/G ratio of 2.27 and a beta of 0.76.

Dolby Laboratories (NYSE:DLB) last issued its quarterly earnings results on Tuesday, April 24th. The electronics maker reported $0.78 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.64 by $0.14. Dolby Laboratories had a net margin of 7.64% and a return on equity of 12.73%. The company had revenue of $301.36 million during the quarter, compared to analyst estimates of $300.37 million. During the same quarter last year, the business posted $0.63 EPS. Dolby Laboratories’s quarterly revenue was up 12.7% compared to the same quarter last year. research analysts expect that Dolby Laboratories, Inc. will post 2.31 earnings per share for the current year.

The business also recently declared a quarterly dividend, which was paid on Wednesday, May 16th. Stockholders of record on Monday, May 7th were paid a dividend of $0.16 per share. The ex-dividend date was Friday, May 4th. This represents a $0.64 annualized dividend and a dividend yield of 1.02%. Dolby Laboratories’s payout ratio is currently 29.09%.

Several hedge funds have recently modified their holdings of DLB. Allianz Asset Management GmbH increased its stake in shares of Dolby Laboratories by 107.3% during the 1st quarter. Allianz Asset Management GmbH now owns 1,167,119 shares of the electronics maker’s stock worth $74,182,000 after purchasing an additional 604,109 shares during the last quarter. Sumitomo Mitsui Asset Management Company LTD purchased a new stake in shares of Dolby Laboratories during the 4th quarter worth approximately $22,952,000. DekaBank Deutsche Girozentrale purchased a new stake in shares of Dolby Laboratories during the 1st quarter worth approximately $16,138,000. Schroder Investment Management Group increased its stake in shares of Dolby Laboratories by 35.1% during the 4th quarter. Schroder Investment Management Group now owns 837,657 shares of the electronics maker’s stock worth $51,935,000 after purchasing an additional 217,773 shares during the last quarter. Finally, Columbus Circle Investors purchased a new stake in shares of Dolby Laboratories during the 1st quarter worth approximately $12,295,000. Institutional investors own 53.97% of the company’s stock.

Several equities research analysts have commented on DLB shares. Zacks Investment Research lowered shares of Dolby Laboratories from a “hold” rating to a “sell” rating in a research note on Monday, January 29th. JPMorgan Chase increased their price objective on shares of Dolby Laboratories from $63.00 to $70.00 and gave the company a “neutral” rating in a research note on Thursday, January 25th. ValuEngine upgraded shares of Dolby Laboratories from a “hold” rating to a “buy” rating in a research note on Thursday, March 1st. B. Riley lowered shares of Dolby Laboratories to a “hold” rating and set a $63.00 price objective for the company. in a research note on Thursday, January 25th. Finally, Barrington Research reiterated a “buy” rating and issued a $78.00 price objective on shares of Dolby Laboratories in a research note on Tuesday, May 1st. One research analyst has rated the stock with a sell rating, four have issued a hold rating and three have assigned a buy rating to the stock. Dolby Laboratories currently has a consensus rating of “Hold” and an average price target of $66.50.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment and communications at the cinema, at home, at work, and on mobile devices. The company develops and licenses its audio technologies, including Dolby Digital Plus for digital television, mobile, and Internet-based services; Dolby Digital, a digital audio coding technology that provides multichannel sound in the home; and AAC & HE-AAC, an audio coding technologies used to broadcast, download, and streaming content.

Insider Buying and Selling by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply